Outpatient Use of Oral Propranolol and Topical Timolol for Infantile Hemangiomas: Survey Results and Comparison with Propranolol Consensus Statement Guidelines

Publisher： John Wiley & Sons Inc

E-ISSN： 1525-1470|32|2|171-179

ISSN： 0736-8046

Source： PEDIATRIC DERMATOLOGY, Vol.32, Iss.2, 2015-03, pp. : 171-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patient Perspectives: Propranolol for infantile hemangiomas

By  

PEDIATRIC DERMATOLOGY, Vol. 33, Iss. 5, 2016-09 ,pp. : 549-550

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment with propranolol for infantile hemangiomas: single‐center experience

By  

JOURNAL OF COSMETIC DERMATOLOGY, Vol. 15, Iss. 3, 2016-09 ,pp. : 296-302

John Wiley & Sons Inc

Access to resources Recommend Favorite

Color Doppler Ultrasound Follow‐Up of Infantile Hemangiomas and Peripheral Vascularity in Patients Treated with Propranolol

By  

PEDIATRIC DERMATOLOGY, Vol. 32, Iss. 4, 2015-07 ,pp. : 468-475

John Wiley & Sons Inc

Access to resources Recommend Favorite

A prospective self‐controlled study of topical timolol 0.5% cream for large superficial infantile hemangiomas

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 4, 2015-04 ,pp. : 363-366

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low‐dose propranolol regimen for infantile haemangioma

By  

JOURNAL OF PAEDIATRICS AND CHILD HEALTH, Vol. 51, Iss. 4, 2015-04 ,pp. : 419-424

John Wiley & Sons Inc

Access to resources Recommend Favorite